poisar

Stocks · News reference

8-K filing — Trinity Capital Inc. (TRNZ)

SEC EDGARSEC EDGAR

Filed: 2026-11-04 AccNo: 0001193125-26-446244 Size: 14 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    Codexis Enters into $60 Million Term Loan Facility with Trinity Capital

    Codexis, Inc. announced a $60 million senior secured term loan agreement with Trinity Capital Inc. to refinance existing debt and provide capital flexibility for advancing its ECO Synthesis Manufacturing Platform for siRNA therapeutic manufacturing. The new facility offers 48 months of interest-only payments followed by a 12-month amortization period beginning November 2030, with post-closing outstanding debt of $42.5 million.

  2. Globenewswire IncNa

    Route 92 Medical Announces $100 Million Corporate Debt Facility

    Route 92 Medical, a neurovascular medical technology company, secured a $100 million senior secured debt facility from Trinity Capital Inc. to support its growth strategy and meet strong product demand. The company's integrated neurovascular platform features proprietary technologies including Tenzing delivery catheters and Monopoint, with products like HiPoint 88 receiving FDA clearance for acute ischemic stroke treatment.